Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1623
    -0.0060 (-0.52%)
     
  • GBP/USD

    1.2385
    -0.0053 (-0.43%)
     
  • Bitcoin GBP

    51,831.15
    +665.70 (+1.30%)
     
  • CMC Crypto 200

    1,380.23
    +67.61 (+5.15%)
     
  • S&P 500

    4,987.65
    -23.47 (-0.47%)
     
  • DOW

    38,009.92
    +234.54 (+0.62%)
     
  • CRUDE OIL

    83.42
    +0.69 (+0.83%)
     
  • GOLD FUTURES

    2,413.90
    +15.90 (+0.66%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

Here’s What’s Overshadowing JNJ’s HIV Vaccine Progress

Here’s What’s Overshadowing JNJ’s HIV Vaccine Progress

According to Bloomberg, Johnson & Johnson (JNJ) plans to initiate a trial to evaluate its mosaic-based HIV-1 vaccine in the US and Europe this year.